From CDC

U.S. COVID-19 Cases, Death Rates Continue to Decrease
While total coronavirus cases reached 33,079,543 as of May 30, CDC data reflects a continuing downward trend in the rate of new infections. A total of 591,265 people have died from the virus so far, an increase of only 240 over the previous two weeks. Over 62% of U.S. adults have received at least one vaccination, and 51.5% are fully vaccinated.

CDC Releases Guidance on Operating Youth Camps
Updated guidance from CDC adds new information on vaccinations, use of masks, planning and preparing for camp, and choosing safer activities. It also includes information for staff or campers who are at increased risk of severe illness from COVID-19.

From EEOC

EEOC: Employers Permitted Require Vaccination
The Equal Employment Opportunity Commission has updated its COVID-19 technical assistance to address vaccination requirements. Employers are permitted to require employees to be vaccinated. They are also allowed to offer incentives to employees to be vaccinated and provide proof of vaccination, as long as employees don't feel pressured to do so.

In the Media

Ten States Reach 70% Vaccination Goal
From CIDRAP: "So far ten states have reached President Biden's July 4 goal of vaccinating 70% of eligible residents against COVID-19, according to White House COVID-19 response coordinator Andy Slavitt. Pennsylvania joined Vermont, Hawaii, New Hampshire, Massachusetts, Connecticut, Maine, New Jersey, Rhode Island, and New Mexico as the tenth state to reach the 70% goal of having citizens with at least one dose of vaccine."

Lower SARS-CoV-2 Vaccine Responses Seen in Patients With Immune-Mediated Inflammatory Diseases
From Medscape: "Ten percent of patients with immune-mediated inflammatory diseases (IMIDs) fail to respond properly to COVID-19 vaccinations regardless of medication, researchers report, and small new studies suggest those on methotrexate and rituximab may be especially vulnerable to vaccine failure."

Vietnam Detects Highly Contagious New Coronavirus Variant as Infections Surge
From Washington Post: "Vietnam’s Health Ministry announced Saturday that it had detected a highly transmissible new variant of the coronavirus that has helped fuel a recent wave of infections in the country. Genetic sequencing indicated that the new variant was a mix of the coronavirus strains first detected in the United Kingdom and India, said Health Minister Nguyen Thanh Long, according to the VnExpress newspaper."

People With PCOS May Be at Higher Risk for COVID-19
From CNN: "More than a year into the pandemic, one study has found that some women are at higher risk for Covid-19 compared to others in their age and sex groups. These women, often young and otherwise healthy like Aguilar, have an underlying condition that isn't mentioned on any Covid-19 comorbidity list: polycystic ovary syndrome, or PCOS."

Postural Orthostatic Tachycardia Syndrome Among Post-COVID-19 Patients Improved through Physical Therapy, Medication, and Diet
From NPR: "A growing number of people are facing mountains of frustration over health problems that linger after COVID-19 with no clear path to improvement. But for a subset of people with what's known as 'long COVID' — mostly women — a (diagnosis of postural-orthostatic tachycardia syndrome) offers a road map to treatment options and relief from their often-debilitating symptoms."

New in Research

Study Suggests High Prevalence of PASC After Severe Infection
In a study published in Clinical Infectious Diseases, researchers found that 52% of 629 Michigan adults experienced symptoms of post-acute sequalae of SARS-Cov-2 30 days after COVID-19 diagnosis, and 35% at 60 days out. Individuals who had severe illness had 2.25 times higher prevalence of 30-day COVID-19 and 1.71 times higher prevalence of 60-day COVID-19 than did individuals with mild symptoms.

Over 70% of Patients With COVID-19 May Experience Long-Term Symptoms
In a systematic review published in JAMA Network Open, the median proportion of individuals who experienced at least one persistent symptom at least 60 days after diagnosis was 72.5%. Authors emphasize the need for further research, as the studies were heterogenous in design.